About Us

All of us are aware of the harmful effects of smoking and how dangerous it can be to our health and environment. Smoking affects each and every part of our body and makes us unfit and unhealthy. Tobacco is full of harmful chemicals that damages different parts of our body.It contain Nicotine which is an addictive drug. According to the American heart Association the nicotine addiction has historically been one of the hardest addiction to break..

To live a healthy and prosperous life it is very essential to quit this bad habit of smoking. However it is not that easy various types of methods are available in the market to help smokers quit this bad habit .But how effective they are it is difficult to say. CHANTIX is the latest prescription medication designed to help people above 18yrs to quit smoking. Chantix is the not a nicotine replacement therapy that are available in the market. Instead chantix blocks nicotine from reaching the receptors in the brain which our associated with addiction to nicotine. It can be said that it reduces the urge or addiction to smoke.

Chantix was developed by the company Pfizer,inc  New York. In May 2006 it was approved by the food and drug administration (FDA).Chantix is used as smoking cessation medicine or treatment. It is used together with behavior modification. Chantix received a priority FDA review because of its potential important benefit to public health. Chantix should be used exactly the way doctor has prescribed it for you. Excess use of chantix may cause certain side effects such as drowsiness which may affect your thinking and reactions.

Chantix contains Varenicline tartarate which blocks the reinforcing effects of nicotine in the brain. Verenicline is a white soluble component that does all the main work. Verenicline is similar to cysitine and is an alternative to NRTs ant nicotine agonist and it has proved much beneficial than other earlier quit smoking drugs.IT is different from nicotinic antagonist,  brupropion and nicotine replacement therapies.Verenicline is in pill form and it releases 35 to 60% of the dopamine that nicotine would have caused to flow if sitting on the exact same acetylcholine receptors.

The recent surveys also tell that Chantix is well tolerated by the smokers who took part in the study. Chantix has 44% success rates in 12 weeks. According to the studies 44% of the people using chantix abstained from smoking. It was also seen that people using bupropian had a 30% success rate whereas people prescribed with chantix had a 51% success rate.